EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)
All Updates

All Updates

icon
Filter
Partnerships
Evolva partners with LEHVOSS for European distribution of Veri-teTM Resveratrol
Alternative Ingredients
Sep 28, 2023
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
Alternative Ingredients

Alternative Ingredients

View industry hub
Sep 28, 2023

Evolva partners with LEHVOSS for European distribution of Veri-teTM Resveratrol

Partnerships

  • Evolva, a Swiss-based producer of natural flavors and fragrances through precision fermentation, has partnered with LEHVOSS UK, a leading European distributor of premium ingredients, to distribute Evolva's Veri-teTM Resveratrol in over a dozen European countries for use in dietary supplements.

  • The company expects this agreement to generate approximately CHF 1.5 million (~USD 1.7 million) in revenue by the end of 2025.

  • Analyst QuickTake: Following the successful market launch of Veri-teTM Resveratrol for use in food and dietary supplements in five Southeast Asian countries (including Thailand and Taiwan ) as well as Brazil , Evolva is now looking to strengthen its distribution in key European countries. Veri-teTM Resveratrol is the main pillar of the company's Health Ingredients (HI) business and contributed 14% YoY HI sales growth in 1H 2023 .

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.